Lol $SAVA it already hit 66 today. Thanks WHC. Price target hit now sell!!!
$SAVA HC Wainwright Buy rating & $66 PT The positive interim analysis from an open-label clinical trial with simufilam for Alzheimer's disease raise potential for signing a "lucrative" deal in 2021, Analyst Vernon Bernardino tells investors in a research note. The analyst believes simufilam's target, altered FLNA, represents a scarcity in Alzheimer's drug development. *The next HUGE positive catalyst will likely be a $PFE $BIIB or $MRK taking a stake in the company and partnering to expedite Phase 3 trials
View original message